Zicai Liu , Zhanxiang Lin , Xuejin Liu , Xiuying Xie , Cheng Tan
{"title":"Application and progress of magnetic field therapy for spinal cord injury","authors":"Zicai Liu , Zhanxiang Lin , Xuejin Liu , Xiuying Xie , Cheng Tan","doi":"10.1016/j.jnrt.2025.100205","DOIUrl":"10.1016/j.jnrt.2025.100205","url":null,"abstract":"<div><div>Spinal cord injury (SCI), which results in severe neurological loss and multiple complications, remains a global health problem. Although SCI is a central nervous system injury, the field of related therapies has shown great promise, with breakthroughs regarding the theory of central nervous system irreparability. However, from the perspective of neuroprosthetics, the relevant basic theories are not always fully recognized or clearly understood, which poses a challenge to clinical practice guidance. Magnetic therapy technology has developed rapidly in recent years, and various magnetic therapy methods have emerged. Magnetic field therapy (MFT), with applications in SCI treatment, is considered a promising strategy for nerve repair and provides a theoretical foundation for subsequent research. MFT, including transcranial magnetic stimulation, static magnetic field, and pulsed electromagnetic field, has been used preclinically, and clinical studies have shown potential efficacy in SCI. Moreover, preclinical studies have revealed that MFT promotes nerve repair, reduces inflammatory responses, improves motor function, and enhances bladder control. They have also demonstrated that MFT is safe in human SCI patients and may improve motor function and pain control. However, its translation from preclinical studies to clinical application faces many challenges, including biological differences, determination of dose and treatment parameters, assessment of safety and side effects, and ethical and regulatory compliance. The present article aims to provide a comprehensive review of the applications and advances of MFT in SCI, to guide future research and provide a reference for clinical treatment. An in-depth discussion of MFT in the field of SCI may provide new ideas and directions for neural repair in SCI.</div></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"13 3","pages":"Article 100205"},"PeriodicalIF":3.1,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143834495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yixuan Yin , Dongning Su , Joyce S.T. Lam , Tao Feng
{"title":"Advances in clinical neurorestorative treatments of Parkinson's disease","authors":"Yixuan Yin , Dongning Su , Joyce S.T. Lam , Tao Feng","doi":"10.1016/j.jnrt.2025.100204","DOIUrl":"10.1016/j.jnrt.2025.100204","url":null,"abstract":"<div><div>Increasing dopamine levels using oral levodopa administration has been the gold standard for treating Parkinson's disease (PD), but motor complications that occur with the progression of PD seriously affect patient quality of life. Neurorestorative treatments have provided new possibilities for PD therapies. This review summarizes the recent clinical progress in several aspects of neurorestorative strategies: cell therapy, bioengineering and tissue engineering therapy, pharmacological therapy, neurostimulation/neuromodulation, and brain–computer interfaces. However, progress has mainly been related to exploratory experimental results, and more evidence is needed to further verify the safety and efficacy of these neurorestorative treatments in PD.</div></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"13 3","pages":"Article 100204"},"PeriodicalIF":3.1,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143848013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dingyu Du , Guipeng Zhao , Yukai Huang , Longyi Chen, Jinping Liu
{"title":"Relationship between major depression and cervical spondylosis: A two-sample bidirectional mendelian randomization study","authors":"Dingyu Du , Guipeng Zhao , Yukai Huang , Longyi Chen, Jinping Liu","doi":"10.1016/j.jnrt.2025.100203","DOIUrl":"10.1016/j.jnrt.2025.100203","url":null,"abstract":"<div><h3>Background</h3><div>This study aimed to explore the causal link between cervical spondylosis (CS) and major depression (MD) using a bidirectional Mendelian randomization (MR) analysis.</div></div><div><h3>Methods</h3><div>Bidirectional MR was employed to validate the bidirectional causal relationship between CS and MD using pooled data obtained from the Integrated Epidemiology Unit Open Genome Wide Association Study (GWAS) database. MR Egger, weighted median, inverse-variance weighted (IVW), and simple mode methods were used, with priority given to IVW results. Sensitivity analyses, including heterogeneity tests, horizontal pleiotropy tests, and leave-one-out methods, were performed to confirm the stability of the MR results.</div></div><div><h3>Results</h3><div>In a forward MR analysis, a causal effect was found between MD and CS (IVW: OR > 1, <em>p</em> < 0.05). However, a reverse MR analysis indicated no causal relationship between CS and MD (<em>p</em> > 0.05). Sensitivity analyses revealed no sample heterogeneity, no horizontal pleiotropy effect, and no significant bias, thus supporting the reliability of the MR analysis results.</div></div><div><h3>Conclusion</h3><div>This study provides evidence demonstrating that MD is causally associated with CS, whereas CS is not causally linked to MD. These findings offer novel insights into the pathogenesis of these two prevalent diseases.</div></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"13 3","pages":"Article 100203"},"PeriodicalIF":3.1,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143759582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chunlei Guo , Jifei Sun , Yue Ma , Shanshan Gao , Tianjiao Xu , Qingyan Chen , Lei Zhang , Jiudong Cao , Guolei Zhang , Yang Hong , Hua Yan , Ge Yang , Jiliang Fang
{"title":"The efficacy of transcutaneous auricular vagus nerve stimulation for patients with mild cognitive impairment and depressive symptoms: A case report and fMRI study","authors":"Chunlei Guo , Jifei Sun , Yue Ma , Shanshan Gao , Tianjiao Xu , Qingyan Chen , Lei Zhang , Jiudong Cao , Guolei Zhang , Yang Hong , Hua Yan , Ge Yang , Jiliang Fang","doi":"10.1016/j.jnrt.2025.100202","DOIUrl":"10.1016/j.jnrt.2025.100202","url":null,"abstract":"<div><div>This case report details a patient diagnosed with mild cognitive impairment concurrently exhibiting depressive symptoms and undergoing 24 weeks of transcutaneous vagus nerve stimulation therapy. After the 24-week treatment, the patient demonstrated notable improvement in both cognitive function and mood. Simultaneously, significant alterations were observed in the patient's temporal pole and medial orbitofrontal gyrus, regions associated with cognition and emotion. Furthermore, the patient continued to maintain a favorable status throughout the follow-up period. Therefore, transcutaneous vagus nerve stimulation may be a potential treatment for patients with mild cognitive impairment and depressive symptoms.</div></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"13 3","pages":"Article 100202"},"PeriodicalIF":3.1,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143825545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Liang Cao , Yi Zhang , Wenjun Pi , Voon Wee Yong , Mengzhou Xue
{"title":"Neuroinflammation and neurorestoration following stroke: Molecular mechanisms and therapeutic approaches","authors":"Liang Cao , Yi Zhang , Wenjun Pi , Voon Wee Yong , Mengzhou Xue","doi":"10.1016/j.jnrt.2025.100201","DOIUrl":"10.1016/j.jnrt.2025.100201","url":null,"abstract":"","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"13 3","pages":"Article 100201"},"PeriodicalIF":3.1,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143734653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lili Liu , Juanjuan Chen , Zhijian Lin, Jun Hu, Yunong Li, Fenli Zhou
{"title":"Neuronal intranuclear inclusion disease with sudden visual impairment","authors":"Lili Liu , Juanjuan Chen , Zhijian Lin, Jun Hu, Yunong Li, Fenli Zhou","doi":"10.1016/j.jnrt.2025.100193","DOIUrl":"10.1016/j.jnrt.2025.100193","url":null,"abstract":"<div><div>Here we report a case of a 67-year-old female patient who presented with headache, limb tremors, and acute complete vision loss. Physical examination revealed bilateral miosis, and diffusion-weighted imaging sequences showed mild diffusion restriction in the subcortical regions of both occipital lobes. Genetic results revealed 85 GGC repeats in the 5′-untranslated region of the <em>NOTCH2NLC</em> gene. The therapeutic effect of dexamethasone and acyclovir was minimal. NIID must be considered in patients with acute onset and various clinical manifestations and imaging findings similar to encephalitis. We hope that our case presentation will enhance clinicians’ awareness of NIID.</div></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"13 3","pages":"Article 100193"},"PeriodicalIF":3.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143609335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Advances in clinical neurorestorative treatments in brain trauma","authors":"Qian Zhou , Wei Shen , Liang Wen","doi":"10.1016/j.jnrt.2025.100191","DOIUrl":"10.1016/j.jnrt.2025.100191","url":null,"abstract":"<div><div>Traumatic brain injury (TBI) is a significant cause of mortality and disability globally, imposing a considerable burden on society and individuals. In recent years, neurorestorative therapies for TBI have attracted widespread attention. Despite the rapid progress in clinical neurorestorative treatments for TBI, few relevant reviews have been published. This review addresses advances in these strategies for patients with TBI, covering cellular therapies, neurostimulation therapies, brain-computer interfaces, pharmacologic therapies, and multidisciplinary therapies. This review aims to serve as a reference for clinical professionals treating patients with TBI, improving neurologic rehabilitation and outcomes for patients with TBI.</div></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"13 3","pages":"Article 100191"},"PeriodicalIF":3.1,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143621214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xuejia Liu , Zhisheng Han , Yuming Huang , Mingzhi Li , Jialu Tian , Shan Zhao , Yonghai Li , Juntang Lin , Han Li
{"title":"HIF1α/SLC7A11 signaling attenuates 6-hydroxydopamine-induced ferroptosis in animal and cell models of Parkinson’s disease","authors":"Xuejia Liu , Zhisheng Han , Yuming Huang , Mingzhi Li , Jialu Tian , Shan Zhao , Yonghai Li , Juntang Lin , Han Li","doi":"10.1016/j.jnrt.2024.100171","DOIUrl":"10.1016/j.jnrt.2024.100171","url":null,"abstract":"<div><h3>Background</h3><div>The pathogenesis of Parkinson’s disease (PD) is associated with ferroptosis. The role of HIF1α is involved in several diseases, but its specific function in PD remains uncertain.</div></div><div><h3>Methods</h3><div>In this study, we generated animal and cellular models of PD using the neurotoxin 6-OHDA. The occurrence of ferroptosis was determined by measuring levels of ferroptosis-related proteins, Fe<sup>2+</sup> amount and transmission electron microscopy analysis in the PD models, and was further confirmed by using a ferroptosis inhibitor. HIF1α overexpressing and HIF1α knockdown SH-SY5Y cells were constructed by lentivirus transfection. Then, the levels of lipid peroxide, ROS, SLC7A11, and GPX4 were detected to elucidate the relationship between HIF1α and ferroptosis. Luciferase assay was used to analyze the regulation between HIF1α and SLC7A11.</div></div><div><h3>Results</h3><div>We observed a significant downregulation of HIF1α in both animal and cellular PD models. Overexpression of HIF1α mitigated 6-OHDA-induced ferroptosis in SH-SY5Y cells, while, conversely, downregulation of HIF1α promoted ferroptosis in SH-SY5Y cells. BioEdit Sequence Alignment Editor software identified a hypoxia response element (HRE) within the promoter sequence of <em>SLC7A11</em>. The dual-luciferase reporter assays demonstrated that the co-expression of HIF1α and the <em>SLC7A11</em> promoter significantly augmented reporter activity in SH-SY5Y cells. Moreover, introduction of a mutation into the HRE of the <em>SLC7A11</em> promoter abolished the induction of SLC7A11 by HIF1α overexpression, resulted in a reduction in promoter activity compared with wild-type cells.</div></div><div><h3>Conclusions</h3><div>The collective findings of this study indicate that HIF1α can inhibit ferroptosis by positively regulating <em>SLC7A11</em>. This investigation has shed light on the crucial involvement of the HIF1α/SLC7A11 signaling axis in ferroptosis in PD models, thereby presenting patients with PD a promising therapeutic target.</div></div>","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"13 1","pages":"Article 100171"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143170170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hongyun Huang, Paul R. Sanberg, Hari Shanker Sharma, Sang Ryong Jeon
{"title":"The responsibility and mission of Neurorestoratology‒New year’s greetings for 2025","authors":"Hongyun Huang, Paul R. Sanberg, Hari Shanker Sharma, Sang Ryong Jeon","doi":"10.1016/j.jnrt.2024.100174","DOIUrl":"10.1016/j.jnrt.2024.100174","url":null,"abstract":"","PeriodicalId":44709,"journal":{"name":"Journal of Neurorestoratology","volume":"13 1","pages":"Article 100174"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143169757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}